WalterTam的个人主页 - 老虎社区

WalterTam

WalterTam

暂无个人介绍

IP属地：未知

18关注

2粉丝

0主题

0勋章

2021-12-22

Gg

Microsoft's $16 billion Nuance bid gets EU antitrust approval

2021-12-25

Jh

3 Best Buffett Stocks to Buy for the Long Haul

2021-12-07

OK

Apple stock surged more than 3% in morning trading

2021-12-12

Ok

3 Top Metaverse Stocks to Buy in December

2021-12-07

OK

Semiconductor stocks dipped in morning trading

2021-12-28

Dd

抱歉，原内容已删除

2021-12-26

uh

抱歉，原内容已删除

2021-12-25

Hh

抱歉，原内容已删除

2021-12-20

Ff

抱歉，原内容已删除

2021-12-20

Ddd

Novavax Climbs as Its Covid Vaccine Recommended for EU Approval

2021-12-16

Dd

抱歉，原内容已删除

2021-12-30

Ff

抱歉，原内容已删除

2021-12-12

Happy

GM eyes $3 billion in investment in Michigan EV plants - source

2021-11-28

Ddd

@TigerTalks:4 Cycles - Singaproe Stock Market

2021-11-28

Cc

@老虎专刊:【老虎周刊】老虎社区一周十大精华文章

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4097750312224460","uuid":"4097750312224460","gmtCreate":1634667067821,"gmtModify":1637078734976,"name":"WalterTam","pinyin":"waltertam","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":18,"tweetSize":15,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":692194519,"gmtCreate":1640869375863,"gmtModify":1640869376107,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ff","listText":"Ff","text":"Ff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692194519","repostId":"1192543822","repostType":4,"repost":{"id":"1192543822","kind":"news","pubTimestamp":1640854270,"share":"https://www.laohu8.com/m/news/1192543822?lang=&edition=full","pubTime":"2021-12-30 16:51","market":"us","language":"en","title":"The Dow's New High Is Hiding This Key Market Rotation","url":"https://stock-news.laohu8.com/highlight/detail?id=1192543822","media":"Motley Fool","summary":"The stock market finished the third-to-last day of the year with new records for the S&P 500 and Dow Jones Industrial Average.","content":"<html><head></head><body><p><b>Key Points</b></p><ul><li>The Dow and S&amp;P 500 hit new records Wednesday.</li><li>The Dow last set a new high in early November.</li><li>Since then, some stocks have done really well, while others have fallen sharply.</li></ul><p>Investors stayed in the holiday spirit for the most part on Wednesday, with solid gains in much of the market that sent the <b>Dow Jones Industrial Average</b>(DJINDICES:^DJI) and <b>S&amp;P 500</b>(SNPINDEX:^GSPC) to record levels. The <b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC), however, missed out on the rally and fell once again, extending its losses from Tuesday.</p><table><thead><tr><th><p><b>Index</b></p></th><th><p><b>Daily Percentage Change</b></p></th><th><p><b>Daily Point Change</b></p></th></tr></thead><tbody><tr><td><p>Dow</p></td><td><p>+0.25%</p></td><td><p>+90</p></td></tr><tr><td><p>S&amp;P 500</p></td><td><p>+0.14%</p></td><td><p>+7</p></td></tr><tr><td><p>Nasdaq</p></td><td><p>(0.10%)</p></td><td><p>(16)</p></td></tr></tbody></table><p>DATA SOURCE: YAHOO! FINANCE.</p><p>The Dow last hit a record high on Nov. 8, and today&#39;s closing level left the average higher by about 40 points from where it was roughly seven weeks ago. Yet among the 30 stocks in the Dow, there&#39;ve been some big swings that show an interest rotation in the market.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4c5b5a91088a7b03dd6f32b475b6069f\" tg-width=\"2000\" tg-height=\"1426\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>Three big winners</b></p><p>The top performers in the Dow since the average last set new all-time highs in early November are all stocks that investors have increasingly turned to as defensive plays. That includes the traditional safe stock <b>Procter &amp; Gamble</b>(NYSE:PG), which has risen 13% in the time between new Dow highs.</p><p>However, investors might need to get used to the idea that tech giants can also be considered to be conservative investments.<b>Apple</b>(NASDAQ:AAPL) has been the best performer over the time period, jumping nearly 20%.Apple combines a lot of attractive features with considerable growth due to its ongoing dominance of the high-end smartphone market but healthy levels of cash flow that support dividends and massive stock buybacks. Similarly,<b>Cisco Systems</b>(NASDAQ:CSCO) picked up 12% since early November, and the ongoing demand for networking upgrades to take advantage of cloud computing and other tech innovations should help support its business regardless of the economic environment. Both tech stocks have attractive valuations that offer value at what could be an inflection point for the market.</p><p><b>On the other side of the coin</b></p><p>If tech value plays are in vogue, more growth-oriented names are still out of favor.<b>Salesforce.com</b>(NYSE:CRM) has been the worst performer in the Dow, falling 18% since early November. The customer relationship management software platform provider has led the rest of the software-as-a-service industry lower, as investors fear that rising interest rates could make it harder for high-growth companies to get capital and might discount their future earnings too much to justify current rich valuations.</p><p>In addition, investors seem to be taking the omicron COVID-19 variant more seriously than much of the general public. Shares of <b>Disney</b>(NYSE:DIS) were down 12% over the past seven weeks, while <b>Boeing</b>(NYSE:BA) saw a 9% drop. Both companies stand to suffer if soaring case counts spur government officials to impose new restrictions on travel and entertainment, and the news comes at a time when many shareholders had hoped that Disney and Boeing had gotten past the worst of their challenges.</p><p><b>Keep an eye on the market</b></p><p>Even when stock markets soar, there are always interesting things happening beneath the surface. By being aware of changing trends, you can sometimes get ahead of them and improve your returns.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Dow's New High Is Hiding This Key Market Rotation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Dow's New High Is Hiding This Key Market Rotation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 16:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/29/the-dows-new-high-is-hiding-this-key-market-rotati/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key PointsThe Dow and S&P 500 hit new records Wednesday.The Dow last set a new high in early November.Since then, some stocks have done really well, while others have fallen sharply.Investors stayed ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/29/the-dows-new-high-is-hiding-this-key-market-rotati/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PG":"宝洁",".SPX":"S&P 500 Index","AAPL":"苹果","CRM":"赛富时",".DJI":"道琼斯","BA":"波音","CSCO":"思科",".IXIC":"NASDAQ Composite"},"source_url":"https://www.fool.com/investing/2021/12/29/the-dows-new-high-is-hiding-this-key-market-rotati/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192543822","content_text":"Key PointsThe Dow and S&P 500 hit new records Wednesday.The Dow last set a new high in early November.Since then, some stocks have done really well, while others have fallen sharply.Investors stayed in the holiday spirit for the most part on Wednesday, with solid gains in much of the market that sent the Dow Jones Industrial Average(DJINDICES:^DJI) and S&P 500(SNPINDEX:^GSPC) to record levels. The Nasdaq Composite(NASDAQINDEX:^IXIC), however, missed out on the rally and fell once again, extending its losses from Tuesday.IndexDaily Percentage ChangeDaily Point ChangeDow+0.25%+90S&P 500+0.14%+7Nasdaq(0.10%)(16)DATA SOURCE: YAHOO! FINANCE.The Dow last hit a record high on Nov. 8, and today's closing level left the average higher by about 40 points from where it was roughly seven weeks ago. Yet among the 30 stocks in the Dow, there've been some big swings that show an interest rotation in the market.IMAGE SOURCE: GETTY IMAGES.Three big winnersThe top performers in the Dow since the average last set new all-time highs in early November are all stocks that investors have increasingly turned to as defensive plays. That includes the traditional safe stock Procter & Gamble(NYSE:PG), which has risen 13% in the time between new Dow highs.However, investors might need to get used to the idea that tech giants can also be considered to be conservative investments.Apple(NASDAQ:AAPL) has been the best performer over the time period, jumping nearly 20%.Apple combines a lot of attractive features with considerable growth due to its ongoing dominance of the high-end smartphone market but healthy levels of cash flow that support dividends and massive stock buybacks. Similarly,Cisco Systems(NASDAQ:CSCO) picked up 12% since early November, and the ongoing demand for networking upgrades to take advantage of cloud computing and other tech innovations should help support its business regardless of the economic environment. Both tech stocks have attractive valuations that offer value at what could be an inflection point for the market.On the other side of the coinIf tech value plays are in vogue, more growth-oriented names are still out of favor.Salesforce.com(NYSE:CRM) has been the worst performer in the Dow, falling 18% since early November. The customer relationship management software platform provider has led the rest of the software-as-a-service industry lower, as investors fear that rising interest rates could make it harder for high-growth companies to get capital and might discount their future earnings too much to justify current rich valuations.In addition, investors seem to be taking the omicron COVID-19 variant more seriously than much of the general public. Shares of Disney(NYSE:DIS) were down 12% over the past seven weeks, while Boeing(NYSE:BA) saw a 9% drop. Both companies stand to suffer if soaring case counts spur government officials to impose new restrictions on travel and entertainment, and the news comes at a time when many shareholders had hoped that Disney and Boeing had gotten past the worst of their challenges.Keep an eye on the marketEven when stock markets soar, there are always interesting things happening beneath the surface. By being aware of changing trends, you can sometimes get ahead of them and improve your returns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696351328,"gmtCreate":1640624036559,"gmtModify":1640624764354,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Dd","listText":"Dd","text":"Dd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696351328","repostId":"1151032995","repostType":2,"repost":{"id":"1151032995","kind":"news","pubTimestamp":1640617060,"share":"https://www.laohu8.com/m/news/1151032995?lang=&edition=full","pubTime":"2021-12-27 22:57","market":"us","language":"en","title":"Apple Stock: What Happens After The Santa Claus Rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=1151032995","media":"TheStreet","summary":"Apple investors have reasons to be more excited about what comes next. Here is what the data suggests might happen to AAPL share price in the next two weeks.Santa Claus almost skipped Wall Street this year. The S&P 500 dipped 3.5% between December 15 and 20, putting into question the year-end rally that some expected to see. But quickly, bullishness came flooding back, as the index jumped 4% in only three days.Figure 1: Apple's Watch, iPhone and iPad in a Christmas theme.If the “Santa Claus rall","content":"<p>Santa Claus rally? Apple investors have reasons to be more excited about what comes next. Here is what the data suggests might happen to AAPL share price in the next two weeks.</p>\n<p>Santa Claus almost skipped Wall Street this year. The S&amp;P 500&nbsp;dipped 3.5% between December 15 and 20, putting into question the year-end rally that some expected to see. But quickly, bullishness came flooding back, as the index jumped 4% in only three days.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f29dc35b16bd6dea058ab34fcedeaffc\" tg-width=\"1240\" tg-height=\"784\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple's Watch, iPhone and iPad in a Christmas theme.</span></p>\n<p>If the “Santa Claus rally” is real, what happens after the Christmas holiday is over? And more importantly for the Apple Maven: which way will Apple stock&nbsp;head next?</p>\n<p><b>Is Santa Claus real?</b></p>\n<p>The first question to ask is whether the Santa Claus rally is even evident in the data, or simply a myth. Do stocks really tend to spike ahead of December 24?</p>\n<p>There are a few different ways to approach this one. I looked first at the S&amp;P 500’s performance over any two-week period since the early 1990s. Then, I compared my findings against the market returns in the two weeks that precede the Christmas break.</p>\n<p>It turns out that yes, the S&amp;P 500 has historically performed better during the pre-holiday period — but only minimally: average two week return of +0.54% vs. the year-round average of +0.45%. If an extra 9 basis points of performance in two weeks seems exciting enough to you, then sure, Santa Claus has been good to Wall Street.</p>\n<p>The same thing can not be said of Apple stock and its investors. For the past three decades or so, AAPL has produced outstanding average two-week returns of +1.22%. However, in the two weeks preceding Santa’s arrival, returns have been dismal: an average loss of -1.33%.</p>\n<p>This observation is consistent with the idea that&nbsp;the holiday period tends to be seasonally weak for Apple shares. December has only been the ninth best month of performance for Apple stock in the year since the launch of the iPhone, in 2007.</p>\n<p>The most likely rationale: investors probably buy into AAPL before the big catalysts, namely the launch of the newest iPhone model in September and Black Friday. During the holiday shopping weeks, investors “sell the news” and shed some of their AAPL holdings.</p>\n<p><b>What next for AAPL?</b></p>\n<p>If Apple investors feel left out of Santa’s list, they should be more excited about what comes next. Since the early 1990s, Apple stock has produced an average gain of +4.83% in the two weeks following Christmas, which is well above average. This is probably a rebound effect from the traditionally dull, pre-Santa performance. See chart below.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/27bca749b86e2d2be63accff7a531f64\" tg-width=\"893\" tg-height=\"456\" width=\"100%\" height=\"auto\"><span>Figure 2: Pre-Santa and Post-Santa two week Returns in AAPL and SPY.</span></p>\n<p>Something similar happens to the S&amp;P 500, although not to the same extent: the average post-Christmas gains of 0.80% tend to be better than those produced by the Santa rally.</p>\n<p>In the next few trading days, will Apple stock and the broad market perform as well as they have in prior years? We will keep monitoring price action through the year-end holiday to find out.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: What Happens After The Santa Claus Rally?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: What Happens After The Santa Claus Rally?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 22:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/news/apple-stock-what-happens-after-the-santa-claus-rally><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Santa Claus rally? Apple investors have reasons to be more excited about what comes next. Here is what the data suggests might happen to AAPL share price in the next two weeks.\nSanta Claus almost ...</p>\n\n<a href=\"https://www.thestreet.com/apple/news/apple-stock-what-happens-after-the-santa-claus-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/news/apple-stock-what-happens-after-the-santa-claus-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151032995","content_text":"Santa Claus rally? Apple investors have reasons to be more excited about what comes next. Here is what the data suggests might happen to AAPL share price in the next two weeks.\nSanta Claus almost skipped Wall Street this year. The S&P 500 dipped 3.5% between December 15 and 20, putting into question the year-end rally that some expected to see. But quickly, bullishness came flooding back, as the index jumped 4% in only three days.\nFigure 1: Apple's Watch, iPhone and iPad in a Christmas theme.\nIf the “Santa Claus rally” is real, what happens after the Christmas holiday is over? And more importantly for the Apple Maven: which way will Apple stock head next?\nIs Santa Claus real?\nThe first question to ask is whether the Santa Claus rally is even evident in the data, or simply a myth. Do stocks really tend to spike ahead of December 24?\nThere are a few different ways to approach this one. I looked first at the S&P 500’s performance over any two-week period since the early 1990s. Then, I compared my findings against the market returns in the two weeks that precede the Christmas break.\nIt turns out that yes, the S&P 500 has historically performed better during the pre-holiday period — but only minimally: average two week return of +0.54% vs. the year-round average of +0.45%. If an extra 9 basis points of performance in two weeks seems exciting enough to you, then sure, Santa Claus has been good to Wall Street.\nThe same thing can not be said of Apple stock and its investors. For the past three decades or so, AAPL has produced outstanding average two-week returns of +1.22%. However, in the two weeks preceding Santa’s arrival, returns have been dismal: an average loss of -1.33%.\nThis observation is consistent with the idea that the holiday period tends to be seasonally weak for Apple shares. December has only been the ninth best month of performance for Apple stock in the year since the launch of the iPhone, in 2007.\nThe most likely rationale: investors probably buy into AAPL before the big catalysts, namely the launch of the newest iPhone model in September and Black Friday. During the holiday shopping weeks, investors “sell the news” and shed some of their AAPL holdings.\nWhat next for AAPL?\nIf Apple investors feel left out of Santa’s list, they should be more excited about what comes next. Since the early 1990s, Apple stock has produced an average gain of +4.83% in the two weeks following Christmas, which is well above average. This is probably a rebound effect from the traditionally dull, pre-Santa performance. See chart below.\nFigure 2: Pre-Santa and Post-Santa two week Returns in AAPL and SPY.\nSomething similar happens to the S&P 500, although not to the same extent: the average post-Christmas gains of 0.80% tend to be better than those produced by the Santa rally.\nIn the next few trading days, will Apple stock and the broad market perform as well as they have in prior years? We will keep monitoring price action through the year-end holiday to find out.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698798047,"gmtCreate":1640528518880,"gmtModify":1640528518946,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"uh","listText":"uh","text":"uh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698798047","repostId":"2189253631","repostType":2,"isVote":1,"tweetType":1,"viewCount":1300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698287013,"gmtCreate":1640408195939,"gmtModify":1640408195939,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Hh","listText":"Hh","text":"Hh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698287013","repostId":"2193407341","repostType":2,"isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698284472,"gmtCreate":1640408113498,"gmtModify":1640408150957,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Jh","listText":"Jh","text":"Jh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698284472","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","kind":"highlight","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝","ABBV":"艾伯维公司","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":962,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691077927,"gmtCreate":1640104573495,"gmtModify":1640104573495,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691077927","repostId":"1131687838","repostType":4,"repost":{"id":"1131687838","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640100532,"share":"https://www.laohu8.com/m/news/1131687838?lang=&edition=full","pubTime":"2021-12-21 23:28","market":"us","language":"en","title":"Microsoft's $16 billion Nuance bid gets EU antitrust approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1131687838","media":"Reuters","summary":"BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)uncondition","content":"<p>BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)unconditional antitrust approval for its $16 billion bid for artificial intelligence and speech technology company Nuance Communications(NUAN.O).</p>\n<p>The deal is Microsoft's second biggest after its $26.2 billion LinkedIn purchase in 2016, and would boost its presence in cloud services for healthcare.</p>\n<p>It has already regulatory approval in the United States and Australia, and Reuters reported earlier this month it was set to receive EU approval.</p>\n<p>The Commission said its investigation into the deal had concluded that it would not significantly reduce competition in markets for transcription software, cloud services, enterprise communication services, PC operating systems and other products.</p>\n<p>\"The proposed transaction would raise no competition concerns on any of the markets examined in the European Economic Area,\" the Commission said.</p>\n<p>U.S.-based Nuance serves 77% of U.S. hospitals and helped launch Apple's(AAPL.O)Siri virtual assistant.</p>\n<p>The Commission said it had examined issues including the overlap between Microsoft and Nuance's transcription software activities, and found that they offered \"very different products\" that, when combined, would continue to face strong competition from other players.</p>\n<p>Tech companies have ramped up acquisitions of AI-focused firms as more integrate this technology into their products and services.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft's $16 billion Nuance bid gets EU antitrust approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft's $16 billion Nuance bid gets EU antitrust approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-21 23:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)unconditional antitrust approval for its $16 billion bid for artificial intelligence and speech technology company Nuance Communications(NUAN.O).</p>\n<p>The deal is Microsoft's second biggest after its $26.2 billion LinkedIn purchase in 2016, and would boost its presence in cloud services for healthcare.</p>\n<p>It has already regulatory approval in the United States and Australia, and Reuters reported earlier this month it was set to receive EU approval.</p>\n<p>The Commission said its investigation into the deal had concluded that it would not significantly reduce competition in markets for transcription software, cloud services, enterprise communication services, PC operating systems and other products.</p>\n<p>\"The proposed transaction would raise no competition concerns on any of the markets examined in the European Economic Area,\" the Commission said.</p>\n<p>U.S.-based Nuance serves 77% of U.S. hospitals and helped launch Apple's(AAPL.O)Siri virtual assistant.</p>\n<p>The Commission said it had examined issues including the overlap between Microsoft and Nuance's transcription software activities, and found that they offered \"very different products\" that, when combined, would continue to face strong competition from other players.</p>\n<p>Tech companies have ramped up acquisitions of AI-focused firms as more integrate this technology into their products and services.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131687838","content_text":"BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)unconditional antitrust approval for its $16 billion bid for artificial intelligence and speech technology company Nuance Communications(NUAN.O).\nThe deal is Microsoft's second biggest after its $26.2 billion LinkedIn purchase in 2016, and would boost its presence in cloud services for healthcare.\nIt has already regulatory approval in the United States and Australia, and Reuters reported earlier this month it was set to receive EU approval.\nThe Commission said its investigation into the deal had concluded that it would not significantly reduce competition in markets for transcription software, cloud services, enterprise communication services, PC operating systems and other products.\n\"The proposed transaction would raise no competition concerns on any of the markets examined in the European Economic Area,\" the Commission said.\nU.S.-based Nuance serves 77% of U.S. hospitals and helped launch Apple's(AAPL.O)Siri virtual assistant.\nThe Commission said it had examined issues including the overlap between Microsoft and Nuance's transcription software activities, and found that they offered \"very different products\" that, when combined, would continue to face strong competition from other players.\nTech companies have ramped up acquisitions of AI-focused firms as more integrate this technology into their products and services.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693658056,"gmtCreate":1640015925389,"gmtModify":1640015933380,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ff","listText":"Ff","text":"Ff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693658056","repostId":"1110189962","repostType":4,"repost":{"id":"1110189962","kind":"news","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640009269,"share":"https://www.laohu8.com/m/news/1110189962?lang=&edition=full","pubTime":"2021-12-20 22:07","market":"us","language":"en","title":"Bluebird Bio Shares Drop 20% After Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Program","url":"https://stock-news.laohu8.com/highlight/detail?id=1110189962","media":"Dow Jones","summary":"Bluebird bio Inc.'s shares were sharply lower early Monday after the Food and Drug Administration pl","content":"<p>Bluebird bio Inc.'s shares were sharply lower early Monday after the Food and Drug Administration placed a partial hold on the company's clinical program for lovotibeglogene autotemcel gene therapy for sickle cell disease.</p>\n<p>The partial, temporary suspension for patients under the age of 18 relates to an investigation by bluebird bio into an adolescent patient with persistent, non-transfusion-dependent anemia following treatment with lovo-cel, now 18 months post-treatment, the company said.</p>\n<p>In premarket trading, the shares were 20% lower after closing last week at $10.62, down more than 60% since the end of last year.</p>\n<p>Bluebird said the adolescent patient is clinically well and there is no evidence of malignancy or clonal predominance.</p>\n<p>Enrollment and dosing for patients 18 and older living with sickle cell disease in its HGB-206, HGB-210 and LTF-307 clinical studies, as well as follow up for treated patients of all ages in all studies, are continuing as planned, the company said.</p>\n<p>\"We have paused enrollment and treatment of patients younger than 18 in our SCD clinical program, and we will continue to work collaboratively with the FDA to understand and address their concerns,\" Chief Medical Officer Richard Colvin said.</p>\n<p>The company said it expects written questions from the FDA in early 2022 and will work quickly to respond in order to resolve the partial hold. It said it is evaluating what impact, if any, the partial clinical hold may have on its first quarter 2023 projected timing for the lovo-cel biologics license application submission.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title> Bluebird Bio Shares Drop 20% After Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n Bluebird Bio Shares Drop 20% After Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Program\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-20 22:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bluebird bio Inc.'s shares were sharply lower early Monday after the Food and Drug Administration placed a partial hold on the company's clinical program for lovotibeglogene autotemcel gene therapy for sickle cell disease.</p>\n<p>The partial, temporary suspension for patients under the age of 18 relates to an investigation by bluebird bio into an adolescent patient with persistent, non-transfusion-dependent anemia following treatment with lovo-cel, now 18 months post-treatment, the company said.</p>\n<p>In premarket trading, the shares were 20% lower after closing last week at $10.62, down more than 60% since the end of last year.</p>\n<p>Bluebird said the adolescent patient is clinically well and there is no evidence of malignancy or clonal predominance.</p>\n<p>Enrollment and dosing for patients 18 and older living with sickle cell disease in its HGB-206, HGB-210 and LTF-307 clinical studies, as well as follow up for treated patients of all ages in all studies, are continuing as planned, the company said.</p>\n<p>\"We have paused enrollment and treatment of patients younger than 18 in our SCD clinical program, and we will continue to work collaboratively with the FDA to understand and address their concerns,\" Chief Medical Officer Richard Colvin said.</p>\n<p>The company said it expects written questions from the FDA in early 2022 and will work quickly to respond in order to resolve the partial hold. It said it is evaluating what impact, if any, the partial clinical hold may have on its first quarter 2023 projected timing for the lovo-cel biologics license application submission.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BLUE":"bluebird bio Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110189962","content_text":"Bluebird bio Inc.'s shares were sharply lower early Monday after the Food and Drug Administration placed a partial hold on the company's clinical program for lovotibeglogene autotemcel gene therapy for sickle cell disease.\nThe partial, temporary suspension for patients under the age of 18 relates to an investigation by bluebird bio into an adolescent patient with persistent, non-transfusion-dependent anemia following treatment with lovo-cel, now 18 months post-treatment, the company said.\nIn premarket trading, the shares were 20% lower after closing last week at $10.62, down more than 60% since the end of last year.\nBluebird said the adolescent patient is clinically well and there is no evidence of malignancy or clonal predominance.\nEnrollment and dosing for patients 18 and older living with sickle cell disease in its HGB-206, HGB-210 and LTF-307 clinical studies, as well as follow up for treated patients of all ages in all studies, are continuing as planned, the company said.\n\"We have paused enrollment and treatment of patients younger than 18 in our SCD clinical program, and we will continue to work collaboratively with the FDA to understand and address their concerns,\" Chief Medical Officer Richard Colvin said.\nThe company said it expects written questions from the FDA in early 2022 and will work quickly to respond in order to resolve the partial hold. It said it is evaluating what impact, if any, the partial clinical hold may have on its first quarter 2023 projected timing for the lovo-cel biologics license application submission.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693651957,"gmtCreate":1640015892591,"gmtModify":1640015892693,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ddd","listText":"Ddd","text":"Ddd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693651957","repostId":"1100495818","repostType":4,"repost":{"id":"1100495818","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640010925,"share":"https://www.laohu8.com/m/news/1100495818?lang=&edition=full","pubTime":"2021-12-20 22:35","market":"us","language":"en","title":"Novavax Climbs as Its Covid Vaccine Recommended for EU Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1100495818","media":"Tiger Newspress","summary":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use o","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Climbs as Its Covid Vaccine Recommended for EU Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Climbs as Its Covid Vaccine Recommended for EU Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-20 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100495818","content_text":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.","news_type":1},"isVote":1,"tweetType":1,"viewCount":968,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607791619,"gmtCreate":1639584406906,"gmtModify":1639585519169,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Dd","listText":"Dd","text":"Dd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607791619","repostId":"1124730835","repostType":2,"isVote":1,"tweetType":1,"viewCount":1015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604982970,"gmtCreate":1639309466640,"gmtModify":1639309466640,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Happy","listText":"Happy","text":"Happy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604982970","repostId":"2190205546","repostType":4,"repost":{"id":"2190205546","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639186643,"share":"https://www.laohu8.com/m/news/2190205546?lang=&edition=full","pubTime":"2021-12-11 09:37","market":"us","language":"en","title":"GM eyes $3 billion in investment in Michigan EV plants - source","url":"https://stock-news.laohu8.com/highlight/detail?id=2190205546","media":"Reuters","summary":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilit","content":"<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GM eyes $3 billion in investment in Michigan EV plants - source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGM eyes $3 billion in investment in Michigan EV plants - source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4559":"巴菲特持仓","BK4555":"新能源车","GM":"通用汽车","BK4566":"资本集团","BK4099":"汽车制造商"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190205546","content_text":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, one with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.\nIf approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.\nGM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.\nThe cost of the Lansing battery plant would be shared with LGES.\nThe Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":989,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604986700,"gmtCreate":1639309431341,"gmtModify":1639309431341,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604986700","repostId":"2190992671","repostType":4,"repost":{"id":"2190992671","kind":"highlight","pubTimestamp":1639280162,"share":"https://www.laohu8.com/m/news/2190992671?lang=&edition=full","pubTime":"2021-12-12 11:36","market":"hk","language":"en","title":"3 Top Metaverse Stocks to Buy in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2190992671","media":"Motley Fool","summary":"Investors have opportunities to build ground-floor positions in the metaverse revolution.","content":"<p>The rise of the metaverse could usher in a new age of commerce and socialization in virtual worlds. This potentially revolutionary trend is just starting to unfold, and businesses and investors alike are scrambling to get in on the ground floor.</p>\n<p>As an emerging medium, it's fair to say the metaverse is a relatively high-risk investment category, but people who back the right companies and projects could go on to enjoy stellar returns over the long term. With that in mind, read on for a look at three top metaverse stocks that are worth adding to your portfolio before the month is out.</p>\n<p><img src=\"https://static.tigerbbs.com/d47eead465efdbbba1ee3bfe3eb56002\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>1. <a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></h2>\n<p>If you had to pick just <a href=\"https://laohu8.com/S/AONE.U\">one</a> company that appears to be positioning itself to lead the charge on the metaverse, <b>Meta Platforms</b> (NASDAQ:FB) would have to be as strong a choice as any. The company's belief in virtual worlds as a major step forward and revolutionary opportunity is so strong that CEO Mark Zuckerberg and his company opted to change the business's name from Facebook to one that reflects its big new growth bet.</p>\n<p>Meta Platforms' incredible resources and massive active user base give the company strong foundations to launch its metaverse projects. Between Facebook, Instagram, and WhatsApp, the company operates some of the world's most popular social media and communications platforms. The company ended its last quarter with 3.6 billion monthly active users -- good for roughly 45% of the world's population.</p>\n<p>In addition to its massive reach and development resources, Meta Platforms has also been an early mover in the metaverse. Even before the term \"metaverse\" entered into the popular lexicon, the company was eyeing virtual reality (VR) as the next revolutionary computing platform. The tech giant's VR division is at the forefront of hardware (through its Oculus headsets) and software in the category, and the company's big acquisitions should help solidify its leadership position in interactive virtual content and services.</p>\n<h2>2. Unity Software</h2>\n<p>Creating immersive virtual worlds is a complex process, but <b>Unity Software</b> (NYSE:U) offers software that can make it much easier. The company provides a development engine for video games and interactive experiences, and it's poised to help usher in the age of the metaverse. With Unity's tools and services, even relatively small teams can craft engaging visuals and worlds that go on to be enjoyed by a wide audience.</p>\n<p>Unity has already emerged as a go-to development engine for the creation of AR (augmented reality) and VR experiences, with roughly 60% of applications in the combined categories using its tools. Roughly 71% of this year's top 1,000 mobile games were also built using the company's development resources.</p>\n<p>Unity managed to grow sales 43% year over year in its most recently reported quarter, particularly impressive because it was lapping a year of explosive growth in 2020. As demand for metaverse content and services increases, Unity looks uniquely well-positioned to help a wide variety of businesses find success in the emerging medium.</p>\n<h2>3. Nvidia</h2>\n<p>Whether through local devices or cloud-based computing platforms, powerful computing hardware is going to play a big role in the evolution of the metaverse. <b>Nvidia</b> (NASDAQ:NVDA) is the leading provider of graphics processing units (GPUs), and the semiconductor specialist will likely be a key components provider for the evolution of virtual worlds.</p>\n<p>In addition to its hardware business, Nvidia is also positioning itself to benefit from the metaverse trend with its Omniverse software platform. Omniverse is a development, productivity, and sharing service tailored for the creation of metaverse experiences, which could turn into a major performance driver for the company.</p>\n<p>Nvidia is already generating very strong margins and looks poised to retain its leadership position in the GPU space. The addition of a substantial software-as-a-service (SaaS) component to its business model could add a major new source of revenue and push its margins even higher.</p>\n<p>Because of long-term growth opportunities for the company's processors in the gaming, cloud computing, artificial intelligence, and machine vision fields, the graphics specialist already had a promising outlook, and the rise of the metaverse is presenting another potentially explosive growth opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Metaverse Stocks to Buy in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Metaverse Stocks to Buy in December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 11:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/3-top-metaverse-stocks-to-buy-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The rise of the metaverse could usher in a new age of commerce and socialization in virtual worlds. This potentially revolutionary trend is just starting to unfold, and businesses and investors alike ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/3-top-metaverse-stocks-to-buy-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","VR":"GLOBAL X METAVERSE ETF","BK4553":"喜马拉雅资本持仓","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4525":"远程办公概念","BK4524":"宅经济概念","NVDA":"英伟达","BK4508":"社交媒体","BK4543":"AI","U":"Unity Software Inc.","BK4077":"互动媒体与服务","BK4527":"明星科技股","BK4141":"半导体产品","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓","BK4529":"IDC概念"},"source_url":"https://www.fool.com/investing/2021/12/11/3-top-metaverse-stocks-to-buy-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190992671","content_text":"The rise of the metaverse could usher in a new age of commerce and socialization in virtual worlds. This potentially revolutionary trend is just starting to unfold, and businesses and investors alike are scrambling to get in on the ground floor.\nAs an emerging medium, it's fair to say the metaverse is a relatively high-risk investment category, but people who back the right companies and projects could go on to enjoy stellar returns over the long term. With that in mind, read on for a look at three top metaverse stocks that are worth adding to your portfolio before the month is out.\n\nImage source: Getty Images.\n1. Meta Platforms\nIf you had to pick just one company that appears to be positioning itself to lead the charge on the metaverse, Meta Platforms (NASDAQ:FB) would have to be as strong a choice as any. The company's belief in virtual worlds as a major step forward and revolutionary opportunity is so strong that CEO Mark Zuckerberg and his company opted to change the business's name from Facebook to one that reflects its big new growth bet.\nMeta Platforms' incredible resources and massive active user base give the company strong foundations to launch its metaverse projects. Between Facebook, Instagram, and WhatsApp, the company operates some of the world's most popular social media and communications platforms. The company ended its last quarter with 3.6 billion monthly active users -- good for roughly 45% of the world's population.\nIn addition to its massive reach and development resources, Meta Platforms has also been an early mover in the metaverse. Even before the term \"metaverse\" entered into the popular lexicon, the company was eyeing virtual reality (VR) as the next revolutionary computing platform. The tech giant's VR division is at the forefront of hardware (through its Oculus headsets) and software in the category, and the company's big acquisitions should help solidify its leadership position in interactive virtual content and services.\n2. Unity Software\nCreating immersive virtual worlds is a complex process, but Unity Software (NYSE:U) offers software that can make it much easier. The company provides a development engine for video games and interactive experiences, and it's poised to help usher in the age of the metaverse. With Unity's tools and services, even relatively small teams can craft engaging visuals and worlds that go on to be enjoyed by a wide audience.\nUnity has already emerged as a go-to development engine for the creation of AR (augmented reality) and VR experiences, with roughly 60% of applications in the combined categories using its tools. Roughly 71% of this year's top 1,000 mobile games were also built using the company's development resources.\nUnity managed to grow sales 43% year over year in its most recently reported quarter, particularly impressive because it was lapping a year of explosive growth in 2020. As demand for metaverse content and services increases, Unity looks uniquely well-positioned to help a wide variety of businesses find success in the emerging medium.\n3. Nvidia\nWhether through local devices or cloud-based computing platforms, powerful computing hardware is going to play a big role in the evolution of the metaverse. Nvidia (NASDAQ:NVDA) is the leading provider of graphics processing units (GPUs), and the semiconductor specialist will likely be a key components provider for the evolution of virtual worlds.\nIn addition to its hardware business, Nvidia is also positioning itself to benefit from the metaverse trend with its Omniverse software platform. Omniverse is a development, productivity, and sharing service tailored for the creation of metaverse experiences, which could turn into a major performance driver for the company.\nNvidia is already generating very strong margins and looks poised to retain its leadership position in the GPU space. The addition of a substantial software-as-a-service (SaaS) component to its business model could add a major new source of revenue and push its margins even higher.\nBecause of long-term growth opportunities for the company's processors in the gaming, cloud computing, artificial intelligence, and machine vision fields, the graphics specialist already had a promising outlook, and the rise of the metaverse is presenting another potentially explosive growth opportunity.","news_type":1},"isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606936416,"gmtCreate":1638806854934,"gmtModify":1638806854934,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"OK","listText":"OK","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606936416","repostId":"1167580246","repostType":4,"repost":{"id":"1167580246","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638802452,"share":"https://www.laohu8.com/m/news/1167580246?lang=&edition=full","pubTime":"2021-12-06 22:54","market":"us","language":"en","title":"Semiconductor stocks dipped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1167580246","media":"Tiger Newspress","summary":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Se","content":"<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries&nbsp;and&nbsp;ON&nbsp;Semiconductor fell between 2% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks dipped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks dipped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries&nbsp;and&nbsp;ON&nbsp;Semiconductor fell between 2% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TXN":"德州仪器","TSM":"台积电","MU":"美光科技","MRVL":"迈威尔科技","NVDA":"英伟达","GFS":"GLOBALFOUNDRIES Inc.","QCOM":"高通","ASML":"阿斯麦","ADI":"亚德诺","AMD":"美国超微公司","ON":"安森美半导体"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167580246","content_text":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606936578,"gmtCreate":1638806813265,"gmtModify":1638806813265,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"OK","listText":"OK","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606936578","repostId":"1117755408","repostType":4,"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600933535,"gmtCreate":1638031052501,"gmtModify":1638031052635,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ddd","listText":"Ddd","text":"Ddd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600933535","repostId":"872412760","repostType":1,"repost":{"id":872412760,"gmtCreate":1637559405648,"gmtModify":1637683148426,"author":{"id":"3527667602250954","authorId":"3527667602250954","name":"TigerTalks","avatar":"https://static.tigerbbs.com/6d0224a45a40df8a325c03820c17dd2a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667602250954","authorIdStr":"3527667602250954"},"themes":[],"title":"4 Cycles - Singaproe Stock Market","htmlText":"Since Singapore moved to a service-focused nation after the millennium, STI has shifted itself from the 1K-2K zone to the&nbsp;2k-3K zone. Many investors got confused between “Passive” and “Value” investing. If they adopt a “Passive” investing style, they will end up feeling frustrated. However, if we recognized that every market is unique to its own, recognizing STI is currently trading in a 2K-3K zone, and likely it will remain in this way, we will see opportunity in each cycle low. We are into the 4th cycle after Wall Street meltdown in 2008: 1st cycle&nbsp;= +114% 2nd cycle = +41% 3rd cycle = +44% 4th cycle = +48% Index is a benchmark, it helps us to derive a better sentiment on the ground, doing our stock pick only when the time is right and vice versa for profit-takings. Many individ","listText":"Since Singapore moved to a service-focused nation after the millennium, STI has shifted itself from the 1K-2K zone to the&nbsp;2k-3K zone. Many investors got confused between “Passive” and “Value” investing. If they adopt a “Passive” investing style, they will end up feeling frustrated. However, if we recognized that every market is unique to its own, recognizing STI is currently trading in a 2K-3K zone, and likely it will remain in this way, we will see opportunity in each cycle low. We are into the 4th cycle after Wall Street meltdown in 2008: 1st cycle&nbsp;= +114% 2nd cycle = +41% 3rd cycle = +44% 4th cycle = +48% Index is a benchmark, it helps us to derive a better sentiment on the ground, doing our stock pick only when the time is right and vice versa for profit-takings. Many individ","text":"Since Singapore moved to a service-focused nation after the millennium, STI has shifted itself from the 1K-2K zone to the 2k-3K zone. Many investors got confused between “Passive” and “Value” investing. If they adopt a “Passive” investing style, they will end up feeling frustrated. However, if we recognized that every market is unique to its own, recognizing STI is currently trading in a 2K-3K zone, and likely it will remain in this way, we will see opportunity in each cycle low. We are into the 4th cycle after Wall Street meltdown in 2008: 1st cycle = +114% 2nd cycle = +41% 3rd cycle = +44% 4th cycle = +48% Index is a benchmark, it helps us to derive a better sentiment on the ground, doing our stock pick only when the time is right and vice versa for profit-takings. Many individ","images":[{"img":"https://static.tigerbbs.com/50cf0093a63906f1ebe3a8e5623b7594","width":"1920","height":"1080"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872412760","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600933251,"gmtCreate":1638031037965,"gmtModify":1638031037965,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"&nbsp;Cc","listText":"&nbsp;Cc","text":"Cc","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600933251","repostId":"877768524","repostType":1,"repost":{"id":877768524,"gmtCreate":1637985666464,"gmtModify":1638008184237,"author":{"id":"35433028694349","authorId":"35433028694349","name":"老虎专刊","avatar":"https://static.laohu8.com/e0b93d50cf0df54ce7b1b746f78db36c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"35433028694349","authorIdStr":"35433028694349"},"themes":[],"title":"【老虎周刊】老虎社区一周十大精华文章","htmlText":"嗨，虎友们好~这里是老虎社区每周更新的栏目“老虎周刊”。 “老虎周刊”精选老虎社区虎友们一周精华写作，希望对您的投资有所助力。 最好发现认识志同道合的虎友，一起投资一起成长。感谢虎友们支持，祝您投资顺利！ 下面进入一周榜单： <a href=\"https://laohu8.com/TW/875231018\" target=\"_blank\">网易云音乐打新的深度解读</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/279327367386116\">@小斯聊新股</a> 本来以为<a target=\"_blank\" href=\"https://laohu8.com/S/NTES\">$网易(NTES)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09899\">$云音乐(09899)$</a> 要到12月份才开始招股，没想到今天就开了哈。我觉得还是值得期待的。 为什么这么说？——这家从5月就递表，心心念念对标最高500亿美元市值<a target=\"_blank\" href=\"https://laohu8.com/S/TME\">$腾讯音乐(TME)$</a> 的最竞力对手，眼睁睁地看着中概股IPO今年“盖高楼”又“楼塌了”的现实，再次鼓起勇气启动了IPO。 <a href=\"https://laohu8.com/TW/872086340\" target=\"_blank\">【我的每周计划】2021年第46周 - 打造你的仪表盘（1）</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/3556673506813374\">@谋定后动</a> 要了解你自己的财务状况，第一步就是先给自己做一个“人口普查”。我们看公司财务","listText":"嗨，虎友们好~这里是老虎社区每周更新的栏目“老虎周刊”。 “老虎周刊”精选老虎社区虎友们一周精华写作，希望对您的投资有所助力。 最好发现认识志同道合的虎友，一起投资一起成长。感谢虎友们支持，祝您投资顺利！ 下面进入一周榜单： <a href=\"https://laohu8.com/TW/875231018\" target=\"_blank\">网易云音乐打新的深度解读</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/279327367386116\">@小斯聊新股</a> 本来以为<a target=\"_blank\" href=\"https://laohu8.com/S/NTES\">$网易(NTES)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09899\">$云音乐(09899)$</a> 要到12月份才开始招股，没想到今天就开了哈。我觉得还是值得期待的。 为什么这么说？——这家从5月就递表，心心念念对标最高500亿美元市值<a target=\"_blank\" href=\"https://laohu8.com/S/TME\">$腾讯音乐(TME)$</a> 的最竞力对手，眼睁睁地看着中概股IPO今年“盖高楼”又“楼塌了”的现实，再次鼓起勇气启动了IPO。 <a href=\"https://laohu8.com/TW/872086340\" target=\"_blank\">【我的每周计划】2021年第46周 - 打造你的仪表盘（1）</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/3556673506813374\">@谋定后动</a> 要了解你自己的财务状况，第一步就是先给自己做一个“人口普查”。我们看公司财务","text":"嗨，虎友们好~这里是老虎社区每周更新的栏目“老虎周刊”。 “老虎周刊”精选老虎社区虎友们一周精华写作，希望对您的投资有所助力。 最好发现认识志同道合的虎友，一起投资一起成长。感谢虎友们支持，祝您投资顺利！ 下面进入一周榜单： 网易云音乐打新的深度解读 发布者：@小斯聊新股 本来以为$网易(NTES)$$云音乐(09899)$ 要到12月份才开始招股，没想到今天就开了哈。我觉得还是值得期待的。 为什么这么说？——这家从5月就递表，心心念念对标最高500亿美元市值$腾讯音乐(TME)$ 的最竞力对手，眼睁睁地看着中概股IPO今年“盖高楼”又“楼塌了”的现实，再次鼓起勇气启动了IPO。 【我的每周计划】2021年第46周 - 打造你的仪表盘（1） 发布者：@谋定后动 要了解你自己的财务状况，第一步就是先给自己做一个“人口普查”。我们看公司财务","images":[{"img":"https://static.tigerbbs.com/d89cf0770c99355fe8e181ce1f138df1","width":"1080","height":"699"},{"img":"https://static.tigerbbs.com/f7c334ea6506b0f12e2920b6914af3d5","width":"622","height":"442"},{"img":"https://static.tigerbbs.com/7d7c5e9917a4231407b41a739be1b275","width":"697","height":"641"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877768524","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":8,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":691077927,"gmtCreate":1640104573495,"gmtModify":1640104573495,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691077927","repostId":"1131687838","repostType":4,"repost":{"id":"1131687838","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640100532,"share":"https://www.laohu8.com/m/news/1131687838?lang=&edition=full","pubTime":"2021-12-21 23:28","market":"us","language":"en","title":"Microsoft's $16 billion Nuance bid gets EU antitrust approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1131687838","media":"Reuters","summary":"BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)uncondition","content":"<p>BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)unconditional antitrust approval for its $16 billion bid for artificial intelligence and speech technology company Nuance Communications(NUAN.O).</p>\n<p>The deal is Microsoft's second biggest after its $26.2 billion LinkedIn purchase in 2016, and would boost its presence in cloud services for healthcare.</p>\n<p>It has already regulatory approval in the United States and Australia, and Reuters reported earlier this month it was set to receive EU approval.</p>\n<p>The Commission said its investigation into the deal had concluded that it would not significantly reduce competition in markets for transcription software, cloud services, enterprise communication services, PC operating systems and other products.</p>\n<p>\"The proposed transaction would raise no competition concerns on any of the markets examined in the European Economic Area,\" the Commission said.</p>\n<p>U.S.-based Nuance serves 77% of U.S. hospitals and helped launch Apple's(AAPL.O)Siri virtual assistant.</p>\n<p>The Commission said it had examined issues including the overlap between Microsoft and Nuance's transcription software activities, and found that they offered \"very different products\" that, when combined, would continue to face strong competition from other players.</p>\n<p>Tech companies have ramped up acquisitions of AI-focused firms as more integrate this technology into their products and services.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft's $16 billion Nuance bid gets EU antitrust approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft's $16 billion Nuance bid gets EU antitrust approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-21 23:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)unconditional antitrust approval for its $16 billion bid for artificial intelligence and speech technology company Nuance Communications(NUAN.O).</p>\n<p>The deal is Microsoft's second biggest after its $26.2 billion LinkedIn purchase in 2016, and would boost its presence in cloud services for healthcare.</p>\n<p>It has already regulatory approval in the United States and Australia, and Reuters reported earlier this month it was set to receive EU approval.</p>\n<p>The Commission said its investigation into the deal had concluded that it would not significantly reduce competition in markets for transcription software, cloud services, enterprise communication services, PC operating systems and other products.</p>\n<p>\"The proposed transaction would raise no competition concerns on any of the markets examined in the European Economic Area,\" the Commission said.</p>\n<p>U.S.-based Nuance serves 77% of U.S. hospitals and helped launch Apple's(AAPL.O)Siri virtual assistant.</p>\n<p>The Commission said it had examined issues including the overlap between Microsoft and Nuance's transcription software activities, and found that they offered \"very different products\" that, when combined, would continue to face strong competition from other players.</p>\n<p>Tech companies have ramped up acquisitions of AI-focused firms as more integrate this technology into their products and services.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131687838","content_text":"BRUSSELS, Dec 21 (Reuters) - The European Commission on Tuesday granted Microsoft(MSFT.O)unconditional antitrust approval for its $16 billion bid for artificial intelligence and speech technology company Nuance Communications(NUAN.O).\nThe deal is Microsoft's second biggest after its $26.2 billion LinkedIn purchase in 2016, and would boost its presence in cloud services for healthcare.\nIt has already regulatory approval in the United States and Australia, and Reuters reported earlier this month it was set to receive EU approval.\nThe Commission said its investigation into the deal had concluded that it would not significantly reduce competition in markets for transcription software, cloud services, enterprise communication services, PC operating systems and other products.\n\"The proposed transaction would raise no competition concerns on any of the markets examined in the European Economic Area,\" the Commission said.\nU.S.-based Nuance serves 77% of U.S. hospitals and helped launch Apple's(AAPL.O)Siri virtual assistant.\nThe Commission said it had examined issues including the overlap between Microsoft and Nuance's transcription software activities, and found that they offered \"very different products\" that, when combined, would continue to face strong competition from other players.\nTech companies have ramped up acquisitions of AI-focused firms as more integrate this technology into their products and services.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698284472,"gmtCreate":1640408113498,"gmtModify":1640408150957,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Jh","listText":"Jh","text":"Jh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698284472","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","kind":"highlight","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝","ABBV":"艾伯维公司","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":962,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606936578,"gmtCreate":1638806813265,"gmtModify":1638806813265,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"OK","listText":"OK","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606936578","repostId":"1117755408","repostType":4,"repost":{"id":"1117755408","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638801900,"share":"https://www.laohu8.com/m/news/1117755408?lang=&edition=full","pubTime":"2021-12-06 22:45","market":"us","language":"en","title":"Apple stock surged more than 3% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1117755408","media":"Tiger Newspress","summary":"Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones f","content":"<p>Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones for the first half of 2021, a nearly 30% year-on-year increase, after demand for its first-ever 5G handsets surged amid the pandemic, according to&nbsp;Nikkei Asia.</p>\n<p>The Cupertino-based tech giant has asked suppliers to build some 95 million to 96 million iPhones, including the latest iPhone 12 range and the older iPhone 11 and iPhone SE, multiple people familiar with the matter said -- though&nbsp;industrywide shortages&nbsp;of key components could threaten that target.</p>\n<p><img src=\"https://static.tigerbbs.com/55a8103513629aeb04b5256e70aa8380\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple stock surged more than 3% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple stock surged more than 3% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones for the first half of 2021, a nearly 30% year-on-year increase, after demand for its first-ever 5G handsets surged amid the pandemic, according to&nbsp;Nikkei Asia.</p>\n<p>The Cupertino-based tech giant has asked suppliers to build some 95 million to 96 million iPhones, including the latest iPhone 12 range and the older iPhone 11 and iPhone SE, multiple people familiar with the matter said -- though&nbsp;industrywide shortages&nbsp;of key components could threaten that target.</p>\n<p><img src=\"https://static.tigerbbs.com/55a8103513629aeb04b5256e70aa8380\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117755408","content_text":"Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones for the first half of 2021, a nearly 30% year-on-year increase, after demand for its first-ever 5G handsets surged amid the pandemic, according to Nikkei Asia.\nThe Cupertino-based tech giant has asked suppliers to build some 95 million to 96 million iPhones, including the latest iPhone 12 range and the older iPhone 11 and iPhone SE, multiple people familiar with the matter said -- though industrywide shortages of key components could threaten that target.","news_type":1},"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604986700,"gmtCreate":1639309431341,"gmtModify":1639309431341,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604986700","repostId":"2190992671","repostType":4,"repost":{"id":"2190992671","kind":"highlight","pubTimestamp":1639280162,"share":"https://www.laohu8.com/m/news/2190992671?lang=&edition=full","pubTime":"2021-12-12 11:36","market":"hk","language":"en","title":"3 Top Metaverse Stocks to Buy in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2190992671","media":"Motley Fool","summary":"Investors have opportunities to build ground-floor positions in the metaverse revolution.","content":"<p>The rise of the metaverse could usher in a new age of commerce and socialization in virtual worlds. This potentially revolutionary trend is just starting to unfold, and businesses and investors alike are scrambling to get in on the ground floor.</p>\n<p>As an emerging medium, it's fair to say the metaverse is a relatively high-risk investment category, but people who back the right companies and projects could go on to enjoy stellar returns over the long term. With that in mind, read on for a look at three top metaverse stocks that are worth adding to your portfolio before the month is out.</p>\n<p><img src=\"https://static.tigerbbs.com/d47eead465efdbbba1ee3bfe3eb56002\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>1. <a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></h2>\n<p>If you had to pick just <a href=\"https://laohu8.com/S/AONE.U\">one</a> company that appears to be positioning itself to lead the charge on the metaverse, <b>Meta Platforms</b> (NASDAQ:FB) would have to be as strong a choice as any. The company's belief in virtual worlds as a major step forward and revolutionary opportunity is so strong that CEO Mark Zuckerberg and his company opted to change the business's name from Facebook to one that reflects its big new growth bet.</p>\n<p>Meta Platforms' incredible resources and massive active user base give the company strong foundations to launch its metaverse projects. Between Facebook, Instagram, and WhatsApp, the company operates some of the world's most popular social media and communications platforms. The company ended its last quarter with 3.6 billion monthly active users -- good for roughly 45% of the world's population.</p>\n<p>In addition to its massive reach and development resources, Meta Platforms has also been an early mover in the metaverse. Even before the term \"metaverse\" entered into the popular lexicon, the company was eyeing virtual reality (VR) as the next revolutionary computing platform. The tech giant's VR division is at the forefront of hardware (through its Oculus headsets) and software in the category, and the company's big acquisitions should help solidify its leadership position in interactive virtual content and services.</p>\n<h2>2. Unity Software</h2>\n<p>Creating immersive virtual worlds is a complex process, but <b>Unity Software</b> (NYSE:U) offers software that can make it much easier. The company provides a development engine for video games and interactive experiences, and it's poised to help usher in the age of the metaverse. With Unity's tools and services, even relatively small teams can craft engaging visuals and worlds that go on to be enjoyed by a wide audience.</p>\n<p>Unity has already emerged as a go-to development engine for the creation of AR (augmented reality) and VR experiences, with roughly 60% of applications in the combined categories using its tools. Roughly 71% of this year's top 1,000 mobile games were also built using the company's development resources.</p>\n<p>Unity managed to grow sales 43% year over year in its most recently reported quarter, particularly impressive because it was lapping a year of explosive growth in 2020. As demand for metaverse content and services increases, Unity looks uniquely well-positioned to help a wide variety of businesses find success in the emerging medium.</p>\n<h2>3. Nvidia</h2>\n<p>Whether through local devices or cloud-based computing platforms, powerful computing hardware is going to play a big role in the evolution of the metaverse. <b>Nvidia</b> (NASDAQ:NVDA) is the leading provider of graphics processing units (GPUs), and the semiconductor specialist will likely be a key components provider for the evolution of virtual worlds.</p>\n<p>In addition to its hardware business, Nvidia is also positioning itself to benefit from the metaverse trend with its Omniverse software platform. Omniverse is a development, productivity, and sharing service tailored for the creation of metaverse experiences, which could turn into a major performance driver for the company.</p>\n<p>Nvidia is already generating very strong margins and looks poised to retain its leadership position in the GPU space. The addition of a substantial software-as-a-service (SaaS) component to its business model could add a major new source of revenue and push its margins even higher.</p>\n<p>Because of long-term growth opportunities for the company's processors in the gaming, cloud computing, artificial intelligence, and machine vision fields, the graphics specialist already had a promising outlook, and the rise of the metaverse is presenting another potentially explosive growth opportunity.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Metaverse Stocks to Buy in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Metaverse Stocks to Buy in December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 11:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/3-top-metaverse-stocks-to-buy-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The rise of the metaverse could usher in a new age of commerce and socialization in virtual worlds. This potentially revolutionary trend is just starting to unfold, and businesses and investors alike ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/3-top-metaverse-stocks-to-buy-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","VR":"GLOBAL X METAVERSE ETF","BK4553":"喜马拉雅资本持仓","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4525":"远程办公概念","BK4524":"宅经济概念","NVDA":"英伟达","BK4508":"社交媒体","BK4543":"AI","U":"Unity Software Inc.","BK4077":"互动媒体与服务","BK4527":"明星科技股","BK4141":"半导体产品","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓","BK4529":"IDC概念"},"source_url":"https://www.fool.com/investing/2021/12/11/3-top-metaverse-stocks-to-buy-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190992671","content_text":"The rise of the metaverse could usher in a new age of commerce and socialization in virtual worlds. This potentially revolutionary trend is just starting to unfold, and businesses and investors alike are scrambling to get in on the ground floor.\nAs an emerging medium, it's fair to say the metaverse is a relatively high-risk investment category, but people who back the right companies and projects could go on to enjoy stellar returns over the long term. With that in mind, read on for a look at three top metaverse stocks that are worth adding to your portfolio before the month is out.\n\nImage source: Getty Images.\n1. Meta Platforms\nIf you had to pick just one company that appears to be positioning itself to lead the charge on the metaverse, Meta Platforms (NASDAQ:FB) would have to be as strong a choice as any. The company's belief in virtual worlds as a major step forward and revolutionary opportunity is so strong that CEO Mark Zuckerberg and his company opted to change the business's name from Facebook to one that reflects its big new growth bet.\nMeta Platforms' incredible resources and massive active user base give the company strong foundations to launch its metaverse projects. Between Facebook, Instagram, and WhatsApp, the company operates some of the world's most popular social media and communications platforms. The company ended its last quarter with 3.6 billion monthly active users -- good for roughly 45% of the world's population.\nIn addition to its massive reach and development resources, Meta Platforms has also been an early mover in the metaverse. Even before the term \"metaverse\" entered into the popular lexicon, the company was eyeing virtual reality (VR) as the next revolutionary computing platform. The tech giant's VR division is at the forefront of hardware (through its Oculus headsets) and software in the category, and the company's big acquisitions should help solidify its leadership position in interactive virtual content and services.\n2. Unity Software\nCreating immersive virtual worlds is a complex process, but Unity Software (NYSE:U) offers software that can make it much easier. The company provides a development engine for video games and interactive experiences, and it's poised to help usher in the age of the metaverse. With Unity's tools and services, even relatively small teams can craft engaging visuals and worlds that go on to be enjoyed by a wide audience.\nUnity has already emerged as a go-to development engine for the creation of AR (augmented reality) and VR experiences, with roughly 60% of applications in the combined categories using its tools. Roughly 71% of this year's top 1,000 mobile games were also built using the company's development resources.\nUnity managed to grow sales 43% year over year in its most recently reported quarter, particularly impressive because it was lapping a year of explosive growth in 2020. As demand for metaverse content and services increases, Unity looks uniquely well-positioned to help a wide variety of businesses find success in the emerging medium.\n3. Nvidia\nWhether through local devices or cloud-based computing platforms, powerful computing hardware is going to play a big role in the evolution of the metaverse. Nvidia (NASDAQ:NVDA) is the leading provider of graphics processing units (GPUs), and the semiconductor specialist will likely be a key components provider for the evolution of virtual worlds.\nIn addition to its hardware business, Nvidia is also positioning itself to benefit from the metaverse trend with its Omniverse software platform. Omniverse is a development, productivity, and sharing service tailored for the creation of metaverse experiences, which could turn into a major performance driver for the company.\nNvidia is already generating very strong margins and looks poised to retain its leadership position in the GPU space. The addition of a substantial software-as-a-service (SaaS) component to its business model could add a major new source of revenue and push its margins even higher.\nBecause of long-term growth opportunities for the company's processors in the gaming, cloud computing, artificial intelligence, and machine vision fields, the graphics specialist already had a promising outlook, and the rise of the metaverse is presenting another potentially explosive growth opportunity.","news_type":1},"isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606936416,"gmtCreate":1638806854934,"gmtModify":1638806854934,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"OK","listText":"OK","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606936416","repostId":"1167580246","repostType":4,"repost":{"id":"1167580246","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638802452,"share":"https://www.laohu8.com/m/news/1167580246?lang=&edition=full","pubTime":"2021-12-06 22:54","market":"us","language":"en","title":"Semiconductor stocks dipped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1167580246","media":"Tiger Newspress","summary":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Se","content":"<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries&nbsp;and&nbsp;ON&nbsp;Semiconductor fell between 2% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks dipped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks dipped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries&nbsp;and&nbsp;ON&nbsp;Semiconductor fell between 2% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TXN":"德州仪器","TSM":"台积电","MU":"美光科技","MRVL":"迈威尔科技","NVDA":"英伟达","GFS":"GLOBALFOUNDRIES Inc.","QCOM":"高通","ASML":"阿斯麦","ADI":"亚德诺","AMD":"美国超微公司","ON":"安森美半导体"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167580246","content_text":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696351328,"gmtCreate":1640624036559,"gmtModify":1640624764354,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Dd","listText":"Dd","text":"Dd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696351328","repostId":"1151032995","repostType":2,"isVote":1,"tweetType":1,"viewCount":1000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698798047,"gmtCreate":1640528518880,"gmtModify":1640528518946,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"uh","listText":"uh","text":"uh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698798047","repostId":"2189253631","repostType":2,"isVote":1,"tweetType":1,"viewCount":1300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698287013,"gmtCreate":1640408195939,"gmtModify":1640408195939,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Hh","listText":"Hh","text":"Hh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698287013","repostId":"2193407341","repostType":2,"isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693658056,"gmtCreate":1640015925389,"gmtModify":1640015933380,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ff","listText":"Ff","text":"Ff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693658056","repostId":"1110189962","repostType":4,"isVote":1,"tweetType":1,"viewCount":1124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693651957,"gmtCreate":1640015892591,"gmtModify":1640015892693,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ddd","listText":"Ddd","text":"Ddd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693651957","repostId":"1100495818","repostType":4,"repost":{"id":"1100495818","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640010925,"share":"https://www.laohu8.com/m/news/1100495818?lang=&edition=full","pubTime":"2021-12-20 22:35","market":"us","language":"en","title":"Novavax Climbs as Its Covid Vaccine Recommended for EU Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1100495818","media":"Tiger Newspress","summary":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use o","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Climbs as Its Covid Vaccine Recommended for EU Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Climbs as Its Covid Vaccine Recommended for EU Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-20 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100495818","content_text":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.","news_type":1},"isVote":1,"tweetType":1,"viewCount":968,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607791619,"gmtCreate":1639584406906,"gmtModify":1639585519169,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Dd","listText":"Dd","text":"Dd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607791619","repostId":"1124730835","repostType":2,"isVote":1,"tweetType":1,"viewCount":1015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692194519,"gmtCreate":1640869375863,"gmtModify":1640869376107,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ff","listText":"Ff","text":"Ff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692194519","repostId":"1192543822","repostType":4,"isVote":1,"tweetType":1,"viewCount":1183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604982970,"gmtCreate":1639309466640,"gmtModify":1639309466640,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Happy","listText":"Happy","text":"Happy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604982970","repostId":"2190205546","repostType":4,"repost":{"id":"2190205546","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639186643,"share":"https://www.laohu8.com/m/news/2190205546?lang=&edition=full","pubTime":"2021-12-11 09:37","market":"us","language":"en","title":"GM eyes $3 billion in investment in Michigan EV plants - source","url":"https://stock-news.laohu8.com/highlight/detail?id=2190205546","media":"Reuters","summary":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilit","content":"<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GM eyes $3 billion in investment in Michigan EV plants - source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGM eyes $3 billion in investment in Michigan EV plants - source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4559":"巴菲特持仓","BK4555":"新能源车","GM":"通用汽车","BK4566":"资本集团","BK4099":"汽车制造商"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190205546","content_text":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, one with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.\nIf approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.\nGM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.\nThe cost of the Lansing battery plant would be shared with LGES.\nThe Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":989,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600933535,"gmtCreate":1638031052501,"gmtModify":1638031052635,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"Ddd","listText":"Ddd","text":"Ddd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600933535","repostId":"872412760","repostType":1,"repost":{"id":872412760,"gmtCreate":1637559405648,"gmtModify":1637683148426,"author":{"id":"3527667602250954","authorId":"3527667602250954","name":"TigerTalks","avatar":"https://static.tigerbbs.com/6d0224a45a40df8a325c03820c17dd2a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667602250954","authorIdStr":"3527667602250954"},"themes":[],"title":"4 Cycles - Singaproe Stock Market","htmlText":"Since Singapore moved to a service-focused nation after the millennium, STI has shifted itself from the 1K-2K zone to the&nbsp;2k-3K zone. Many investors got confused between “Passive” and “Value” investing. If they adopt a “Passive” investing style, they will end up feeling frustrated. However, if we recognized that every market is unique to its own, recognizing STI is currently trading in a 2K-3K zone, and likely it will remain in this way, we will see opportunity in each cycle low. We are into the 4th cycle after Wall Street meltdown in 2008: 1st cycle&nbsp;= +114% 2nd cycle = +41% 3rd cycle = +44% 4th cycle = +48% Index is a benchmark, it helps us to derive a better sentiment on the ground, doing our stock pick only when the time is right and vice versa for profit-takings. Many individ","listText":"Since Singapore moved to a service-focused nation after the millennium, STI has shifted itself from the 1K-2K zone to the&nbsp;2k-3K zone. Many investors got confused between “Passive” and “Value” investing. If they adopt a “Passive” investing style, they will end up feeling frustrated. However, if we recognized that every market is unique to its own, recognizing STI is currently trading in a 2K-3K zone, and likely it will remain in this way, we will see opportunity in each cycle low. We are into the 4th cycle after Wall Street meltdown in 2008: 1st cycle&nbsp;= +114% 2nd cycle = +41% 3rd cycle = +44% 4th cycle = +48% Index is a benchmark, it helps us to derive a better sentiment on the ground, doing our stock pick only when the time is right and vice versa for profit-takings. Many individ","text":"Since Singapore moved to a service-focused nation after the millennium, STI has shifted itself from the 1K-2K zone to the 2k-3K zone. Many investors got confused between “Passive” and “Value” investing. If they adopt a “Passive” investing style, they will end up feeling frustrated. However, if we recognized that every market is unique to its own, recognizing STI is currently trading in a 2K-3K zone, and likely it will remain in this way, we will see opportunity in each cycle low. We are into the 4th cycle after Wall Street meltdown in 2008: 1st cycle = +114% 2nd cycle = +41% 3rd cycle = +44% 4th cycle = +48% Index is a benchmark, it helps us to derive a better sentiment on the ground, doing our stock pick only when the time is right and vice versa for profit-takings. Many individ","images":[{"img":"https://static.tigerbbs.com/50cf0093a63906f1ebe3a8e5623b7594","width":"1920","height":"1080"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872412760","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600933251,"gmtCreate":1638031037965,"gmtModify":1638031037965,"author":{"id":"4097750312224460","authorId":"4097750312224460","name":"WalterTam","avatar":"https://static.tigerbbs.com/7a7fb7742720e323386860258ca7af87","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097750312224460","authorIdStr":"4097750312224460"},"themes":[],"htmlText":"&nbsp;Cc","listText":"&nbsp;Cc","text":"Cc","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600933251","repostId":"877768524","repostType":1,"repost":{"id":877768524,"gmtCreate":1637985666464,"gmtModify":1638008184237,"author":{"id":"35433028694349","authorId":"35433028694349","name":"老虎专刊","avatar":"https://static.laohu8.com/e0b93d50cf0df54ce7b1b746f78db36c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"35433028694349","authorIdStr":"35433028694349"},"themes":[],"title":"【老虎周刊】老虎社区一周十大精华文章","htmlText":"嗨，虎友们好~这里是老虎社区每周更新的栏目“老虎周刊”。 “老虎周刊”精选老虎社区虎友们一周精华写作，希望对您的投资有所助力。 最好发现认识志同道合的虎友，一起投资一起成长。感谢虎友们支持，祝您投资顺利！ 下面进入一周榜单： <a href=\"https://laohu8.com/TW/875231018\" target=\"_blank\">网易云音乐打新的深度解读</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/279327367386116\">@小斯聊新股</a> 本来以为<a target=\"_blank\" href=\"https://laohu8.com/S/NTES\">$网易(NTES)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09899\">$云音乐(09899)$</a> 要到12月份才开始招股，没想到今天就开了哈。我觉得还是值得期待的。 为什么这么说？——这家从5月就递表，心心念念对标最高500亿美元市值<a target=\"_blank\" href=\"https://laohu8.com/S/TME\">$腾讯音乐(TME)$</a> 的最竞力对手，眼睁睁地看着中概股IPO今年“盖高楼”又“楼塌了”的现实，再次鼓起勇气启动了IPO。 <a href=\"https://laohu8.com/TW/872086340\" target=\"_blank\">【我的每周计划】2021年第46周 - 打造你的仪表盘（1）</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/3556673506813374\">@谋定后动</a> 要了解你自己的财务状况，第一步就是先给自己做一个“人口普查”。我们看公司财务","listText":"嗨，虎友们好~这里是老虎社区每周更新的栏目“老虎周刊”。 “老虎周刊”精选老虎社区虎友们一周精华写作，希望对您的投资有所助力。 最好发现认识志同道合的虎友，一起投资一起成长。感谢虎友们支持，祝您投资顺利！ 下面进入一周榜单： <a href=\"https://laohu8.com/TW/875231018\" target=\"_blank\">网易云音乐打新的深度解读</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/279327367386116\">@小斯聊新股</a> 本来以为<a target=\"_blank\" href=\"https://laohu8.com/S/NTES\">$网易(NTES)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/09899\">$云音乐(09899)$</a> 要到12月份才开始招股，没想到今天就开了哈。我觉得还是值得期待的。 为什么这么说？——这家从5月就递表，心心念念对标最高500亿美元市值<a target=\"_blank\" href=\"https://laohu8.com/S/TME\">$腾讯音乐(TME)$</a> 的最竞力对手，眼睁睁地看着中概股IPO今年“盖高楼”又“楼塌了”的现实，再次鼓起勇气启动了IPO。 <a href=\"https://laohu8.com/TW/872086340\" target=\"_blank\">【我的每周计划】2021年第46周 - 打造你的仪表盘（1）</a> 发布者：<a target=\"_blank\" href=\"https://laohu8.com/U/3556673506813374\">@谋定后动</a> 要了解你自己的财务状况，第一步就是先给自己做一个“人口普查”。我们看公司财务","text":"嗨，虎友们好~这里是老虎社区每周更新的栏目“老虎周刊”。 “老虎周刊”精选老虎社区虎友们一周精华写作，希望对您的投资有所助力。 最好发现认识志同道合的虎友，一起投资一起成长。感谢虎友们支持，祝您投资顺利！ 下面进入一周榜单： 网易云音乐打新的深度解读 发布者：@小斯聊新股 本来以为$网易(NTES)$$云音乐(09899)$ 要到12月份才开始招股，没想到今天就开了哈。我觉得还是值得期待的。 为什么这么说？——这家从5月就递表，心心念念对标最高500亿美元市值$腾讯音乐(TME)$ 的最竞力对手，眼睁睁地看着中概股IPO今年“盖高楼”又“楼塌了”的现实，再次鼓起勇气启动了IPO。 【我的每周计划】2021年第46周 - 打造你的仪表盘（1） 发布者：@谋定后动 要了解你自己的财务状况，第一步就是先给自己做一个“人口普查”。我们看公司财务","images":[{"img":"https://static.tigerbbs.com/d89cf0770c99355fe8e181ce1f138df1","width":"1080","height":"699"},{"img":"https://static.tigerbbs.com/f7c334ea6506b0f12e2920b6914af3d5","width":"622","height":"442"},{"img":"https://static.tigerbbs.com/7d7c5e9917a4231407b41a739be1b275","width":"697","height":"641"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877768524","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":8,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}